Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06347380 · ClinicalTrials.gov registry record · NA
Usability Study of the FemPulse System
A NA study, sponsored by FemPulse Corporation.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT06347380: Completed NA study, sponsored by FemPulse Corporation.
NCT06347380 is a NA study that has completed, run by FemPulse Corporation. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06347380, a NA study, has completed, sponsored by FemPulse Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The objective of the study is to demonstrate that the FemPulse System can be used as indicated in the Instructions for Use (IFU), as applicable.
Primary Outcome
Proportion of subjects reporting satisfaction with the use of the FemPulse System
Interventions
- DEVICE FemPulse System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2024-09-11 |
| Est. Completion | 2025-07-31 |
| Phase | NA |
What the finished NCT06347380 record still lists
NCT06347380 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which FemPulse System is the first listed.
NCT06347380 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06347380 about?
NCT06347380 is a clinical study titled "Usability Study of the FemPulse System". The objective of the study is to demonstrate that the FemPulse System can be used as indicated in the Instructions for Use (IFU), as applicable.
What is the current status of trial NCT06347380?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2024-09-11. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT06347380?
The interventions under investigation include: FemPulse System (DEVICE).
Who is sponsoring clinical trial NCT06347380?
This trial is sponsored by FemPulse Corporation, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06347380's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI